AR and asthma: These findings reveal that allergic airway diseases share a core metabolic disturbances that may reflect immune dysregulation and potentially involve gut dysbiosis, and yet exhibit distinct profiles: AR shows localized amino acid perturbations, asthma displays systemic lipid remodeling, and CARAS manifests as a distinct comorbid phenotype combining both features.